Xeris Biopharma Holdings Inc (XERS)

04:15 AM

Why Xeris Biopharma Holdings (XERS) Is Up 7.9% After Raising 2025 Revenue Outlook and Adding Patents - Yahoo Finance

04:15 AM

Jan 09, 2026

XERS: HC Wainwright & Co. Reiterates Buy Rating with $10.00 Pric - GuruFocus

Jan 09, 2026

Jan 09, 2026

Will Xeris Biopharma Holdings Inc. stock pay special dividendsJuly 2025 WrapUp & Consistent Profit Trade Alerts - ulpravda.ru

Jan 09, 2026

Jan 08, 2026

Will Xeris Biopharma Holdings Inc. stock outperform tech sector in 20252025 EndofYear Setup & Weekly High Potential Stock Alerts - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Xeris Biopharma (XERS) Exceeds 2025 Revenue Expectations - GuruFocus

Jan 08, 2026

Jan 08, 2026

Breakout Move: Is Xeris Biopharma Holdings Inc. stock a smart buy before Fed meetingJuly 2025 Trade Ideas & AI Driven Price Predictions - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

How Xeris Biopharma Holdings Inc. stock benefits from strong dollarJuly 2025 Update & AI Powered Buy and Sell Recommendations - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Is Xeris Biopharma Holdings Inc. stock positioned well for digital economyBreakout Watch & Smart Allocation Stock Reports - ulpravda.ru

Jan 08, 2026

Jan 08, 2026

Xeris Biopharma expects full-year 2025 revenue above estimates - MSN

Jan 08, 2026

Jan 08, 2026

Xeris Expects to Deliver Record Fourth Quarter and Full-Year 2025 Total Revenue - BioSpace

Jan 08, 2026

Jan 08, 2026

A biotech treating 700 patients is on track for a record revenue year - Stock Titan

Jan 08, 2026

Jan 06, 2026

Xeris Biopharma director Shannon sells $176k in shares By Investing.com - Investing.com Canada

Jan 06, 2026

Jan 06, 2026

Xeris Biopharma director Shannon sells $176k in shares - Investing.com India

Jan 06, 2026

Jan 05, 2026

Beth Hecht Sells 16,667 Shares of Xeris Biopharma (NASDAQ:XERS) Stock - MarketBeat

Jan 05, 2026

Jan 05, 2026

Xeris Biopharma Holdings, Inc. $XERS Shares Sold by Diversified Trust Co - MarketBeat

Jan 05, 2026

Jan 02, 2026

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire

Jan 02, 2026

Jan 02, 2026

Xeris Biopharma (NASDAQ:XERS) Trading Down 6.8%Time to Sell? - MarketBeat

Jan 02, 2026

Jan 02, 2026

Calamos Advisors LLC Makes New Investment in Xeris Biopharma Holdings, Inc. $XERS - MarketBeat

Jan 02, 2026

Dec 31, 2025

Why Xeris Biopharma Stock Zoomed 7% Higher on Wednesday - Finviz

Dec 31, 2025

Dec 31, 2025

Is Xeris Biopharma on the Verge of a Breakthrough? - StocksToTrade

Dec 31, 2025

Dec 31, 2025

Xeris Biopharma Holdings Inc. (XERS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 31, 2025

Dec 31, 2025

XERS FinancialsIncome Statement - Quiver Quantitative

Dec 31, 2025

Dec 31, 2025

Xeris Biopharma (NASDAQ:XERS) Shares Gap UpShould You Buy? - MarketBeat

Dec 31, 2025

Dec 31, 2025

Investors Buy Large Volume of Call Options on Xeris Biopharma (NASDAQ:XERS) - MarketBeat

Dec 31, 2025

Dec 31, 2025

Jefferies reiterates Buy rating on Xeris Pharmaceuticals stock amid competitor setback By Investing.com - Investing.com Nigeria

Dec 31, 2025

Dec 31, 2025

Jefferies reiterates Buy rating on Xeris Pharmaceuticals stock amid competitor setback - Investing.com

Dec 31, 2025

Dec 28, 2025

Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue? - MSN

Dec 28, 2025

Dec 27, 2025

Xeris Biopharma Holdings, Inc. $XERS Shares Acquired by Voya Investment Management LLC - MarketBeat

Dec 27, 2025

Dec 26, 2025

Oppenheimer Maintains Xeris Biopharma Holdings (XERS) Outperform Recommendation - MSN

Dec 26, 2025

Dec 23, 2025

Have Xeris Biopharma Holdings Insiders Been Selling Stock? - Sahm

Dec 23, 2025

Dec 21, 2025

Will Xeris Biopharma Holdings Inc. stock benefit from sector rotationJuly 2025 Technicals & High Accuracy Buy Signal Tips - Улправда

Dec 21, 2025

Dec 21, 2025

Squarepoint Ops LLC Purchases 268,572 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat

Dec 21, 2025

Dec 20, 2025

Xeris Biopharma (XERS): Assessing Valuation as Investors Back Its Shift to Profitable Specialty Pharma - Sahm

Dec 20, 2025

Dec 20, 2025

EBIT per share of Xeris Biopharma Holdings, Inc. – LSE:0A8E - TradingView — Track All Markets

Dec 20, 2025

Dec 20, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 20, 2025

Dec 19, 2025

Director John Johnson Sells 135,400 Shares of Xeris Biopharma Ho - GuruFocus

Dec 19, 2025

Dec 19, 2025

Xeris Biopharma (NASDAQ:XERS) Director Sells $977,588.00 in Stock - MarketBeat

Dec 19, 2025

Dec 19, 2025

Xeris Biopharma Holdings Insider Sold Shares Worth $977,019, According to a Recent SEC Filing - marketscreener.com

Dec 19, 2025

Dec 19, 2025

Will Xeris Biopharma Holdings Inc. stock reach all time highs in 20252025 Investor Takeaways & Free Long-Term Investment Growth Plans - DonanımHaber

Dec 19, 2025

Dec 19, 2025

How Xeris Biopharma’s Shift Toward Profitability and Pipeline Maturity Will Impact Xeris (XERS) Investors - Sahm

Dec 19, 2025

Dec 19, 2025

Is Xeris Biopharma Holdings Inc. stock a contrarian buyJuly 2025 Selloffs & Safe Entry Point Alerts - Улправда

Dec 19, 2025

Dec 18, 2025

Xeris Biopharma Holdings, Inc. (XERS): A Bull Case Theory - Finviz

Dec 18, 2025

Dec 18, 2025

Xeris Biopharma: A Balanced Perspective Needed (Rating Downgrade) - Seeking Alpha

Dec 18, 2025

Dec 15, 2025

Insider Selling: Xeris Biopharma (NASDAQ:XERS) Director Sells 15,000 Shares of Stock - MarketBeat

Dec 15, 2025

Dec 15, 2025

Insider Sell: Barbara-jean Bormann-kennedy Sells 15,000 Shares o - GuruFocus

Dec 15, 2025

Dec 15, 2025

Xeris Biopharma (XERS) director reports 15,000-share stock sale - Stock Titan

Dec 15, 2025

Dec 11, 2025

Walleye Capital LLC Sells 448,444 Shares of Xeris Biopharma Holdings, Inc. $XERS - MarketBeat

Dec 11, 2025